Keynote | How Inflammation Promotes Atherosclerosis and What Can We Do About It from Mechanism to Therapy

Sunday, March 9, 2025

8:56 AM – 9:11 AM ET

Speaker(s)

Peter Libby, MD

Cardiovascular Specialist
Brigham and Women's Hospital
Boston, Massachusetts, United States

Disclosure(s): Amgen: Consultant (Ongoing), Scientific Advisory Board (Ongoing); Baim Institute: Consultant (Ongoing); Beren Therapeutics: Consultant (Ongoing); Caristo Diagnostics: Scientific Advisory Board (Ongoing); CSL Behring: Scientific Advisory Board (Ongoing); Elucid Bioimaging: Scientific Advisory Board (Ongoing); Esperion Therapeutics: Consultant (Ongoing); Genentech: Consultant (Ongoing), Grant/Research Support (Ongoing); Kancera: Consultant (Ongoing), Scientific Advisory Board (Ongoing); Kowa Pharmaceuticals: Consultant (Ongoing), Scientific Advisory Board (Ongoing); Novartis: Consultant (Ongoing), Grant/Research Support (Ongoing), Scientific Advisory Board (Ongoing); Novo Nordisk: Consultant (Ongoing), Grant/Research Support (Ongoing); Olatec Therapeutics: Scientific Advisory Board (Ongoing); PlaqueTec Ltd: Scientific Advisory Board (Ongoing); Polygon Therapeutics: Scientific Advisory Board (Ongoing); Sanofi-Regeneron: Consultant (Ongoing); Soley Thereapeutics: Financial Interest (Ongoing); TenSixteen Bio: Financial Interest (Ongoing); XBiotech, Inc.: Board of Directors (Ongoing), Employee (Ongoing)

Disclosure(s):

Peter Libby, MD: Amgen: Consultant (Ongoing), Scientific Advisory Board (Ongoing); Baim Institute: Consultant (Ongoing); Beren Therapeutics: Consultant (Ongoing); Caristo Diagnostics: Scientific Advisory Board (Ongoing); CSL Behring: Scientific Advisory Board (Ongoing); Elucid Bioimaging: Scientific Advisory Board (Ongoing); Esperion Therapeutics: Consultant (Ongoing); Genentech: Consultant (Ongoing), Grant/Research Support (Ongoing); Kancera: Consultant (Ongoing), Scientific Advisory Board (Ongoing); Kowa Pharmaceuticals: Consultant (Ongoing), Scientific Advisory Board (Ongoing); Novartis: Consultant (Ongoing), Grant/Research Support (Ongoing), Scientific Advisory Board (Ongoing); Novo Nordisk: Consultant (Ongoing), Grant/Research Support (Ongoing); Olatec Therapeutics: Scientific Advisory Board (Ongoing); PlaqueTec Ltd: Scientific Advisory Board (Ongoing); Polygon Therapeutics: Scientific Advisory Board (Ongoing); Sanofi-Regeneron: Consultant (Ongoing); Soley Thereapeutics: Financial Interest (Ongoing); TenSixteen Bio: Financial Interest (Ongoing); XBiotech, Inc.: Board of Directors (Ongoing), Employee (Ongoing)